119 related articles for article (PubMed ID: 35879498)
1. Proteomic analysis of inhibitory protein profiles in the urine of children with nephrolithiasis: implication for disease prevention.
Kovacevic L; Kovacevic N; Lakshmanan Y
Int Urol Nephrol; 2022 Nov; 54(11):2783-2788. PubMed ID: 35879498
[TBL] [Abstract][Full Text] [Related]
2. Marked increase in urinary excretion of apolipoproteins in children with nephrolithiasis associated with hypercalciuria.
Kovacevic L; Lu H; Caruso JA; Govil-Dalela T; Thomas R; Lakshmanan Y
Pediatr Nephrol; 2017 Jun; 32(6):1029-1033. PubMed ID: 28188435
[TBL] [Abstract][Full Text] [Related]
3. Cystatin C, Neutrophil Gelatinase-associated Lipocalin, and Lysozyme C: Urinary Biomarkers for Detection of Early Kidney Dysfunction in Children With Urolithiasis.
Kovacevic L; Lu H; Kovacevic N; Thomas R; Lakshmanan Y
Urology; 2020 Sep; 143():221-226. PubMed ID: 32505622
[TBL] [Abstract][Full Text] [Related]
4. Urine proteomic analysis in cystinuric children with renal stones.
Kovacevic L; Lu H; Goldfarb DS; Lakshmanan Y; Caruso JA
J Pediatr Urol; 2015 Aug; 11(4):217.e1-6. PubMed ID: 26076823
[TBL] [Abstract][Full Text] [Related]
5. Urinary proteomics reveals association between pediatric nephrolithiasis and cardiovascular disease.
Kovacevic L; Lu H; Caruso JA; Kovacevic N; Lakshmanan Y
Int Urol Nephrol; 2018 Nov; 50(11):1949-1954. PubMed ID: 30209738
[TBL] [Abstract][Full Text] [Related]
6. Renal Tubular Dysfunction in Pediatric Urolithiasis: Proteomic Evidence.
Kovacevic L; Lu H; Caruso JA; Lakshmanan Y
Urology; 2016 Jun; 92():100-5. PubMed ID: 26892647
[TBL] [Abstract][Full Text] [Related]
7. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
[TBL] [Abstract][Full Text] [Related]
8. Urinary citrate and renal stone disease: the preventive role of alkali citrate treatment.
Caudarella R; Vescini F
Arch Ital Urol Androl; 2009 Sep; 81(3):182-7. PubMed ID: 19911682
[TBL] [Abstract][Full Text] [Related]
9. [Citrate and kidney stones].
Osther PJ
Ugeskr Laeger; 1993 Nov; 155(47):3835-9. PubMed ID: 8256384
[TBL] [Abstract][Full Text] [Related]
10. Urine proteomic profiling in patients with nephrolithiasis and cystinuria.
Kovacevic L; Caruso JA; Lu H; Kovacevic N; Lakshmanan Y; Carruthers NJ; Goldfarb DS
Int Urol Nephrol; 2019 Apr; 51(4):593-599. PubMed ID: 30519981
[TBL] [Abstract][Full Text] [Related]
11. Can urine osteopontin levels, which may be correlated with nutrition intake and body composition, be used as a new biomarker in the diagnosis of nephrolithiasis?
Icer MA; Gezmen-Karadag M; Sozen S
Clin Biochem; 2018 Sep; 60():38-43. PubMed ID: 30114399
[TBL] [Abstract][Full Text] [Related]
12. [Sodium excretion in children with lithogenic disorders].
Kovacević L; Kovacević S; Smoljanić Z; Peco-Antić A; Kostić N; Gajić M; Kovacević N; Jovanović O
Srp Arh Celok Lek; 1998; 126(9-10):321-6. PubMed ID: 9863402
[TBL] [Abstract][Full Text] [Related]
13. [Urinary citrate excretion in children with calcium urolithiasis].
Sikora P; Bieniaś B; Majewski M; Borzecka H; Wawrzyszuk M; Zajaczkowska M
Przegl Lek; 2006; 63 Suppl 3():134-6. PubMed ID: 16898511
[TBL] [Abstract][Full Text] [Related]
14. Renal excretion of citrate in patients with chronic renal failure or nephrolithiasis.
Chen SM; Chung LC; Lee YH; Young TK
J Formos Med Assoc; 1991 Jan; 90(1):41-7. PubMed ID: 1679108
[TBL] [Abstract][Full Text] [Related]
15. Urinary stone risk factors in the descendants of patients with kidney stone disease.
Dissayabutra T; Kalpongkul N; Rattanaphan J; Boonla C; Srisa-Art M; Ungjaroenwathana W; Tosukhowong P
Pediatr Nephrol; 2018 Jul; 33(7):1173-1181. PubMed ID: 29594505
[TBL] [Abstract][Full Text] [Related]
16. Age, Body Mass Index, and Gender Predict 24-Hour Urine Parameters in Recurrent Idiopathic Calcium Oxalate Stone Formers.
Otto BJ; Bozorgmehri S; Kuo J; Canales M; Bird VG; Canales B
J Endourol; 2017 Dec; 31(12):1335-1341. PubMed ID: 29084490
[TBL] [Abstract][Full Text] [Related]
17. Influence of BMI in nephrolithiasis in an Appalachian pediatric population: A single-center experience.
Murphy MO; Erpelding SG; Chishti AS; Dugan A; Ziada A; Kiessling SG
J Pediatr Urol; 2018 Aug; 14(4):330.e1-330.e8. PubMed ID: 29887297
[TBL] [Abstract][Full Text] [Related]
18. Urinary citrate in kidney stone disease.
Usui Y; Matsuzaki S; Matsushita K; Shima M
Tokai J Exp Clin Med; 2003 Jul; 28(2):65-70. PubMed ID: 14714831
[TBL] [Abstract][Full Text] [Related]
19. Insulin resistance and low urinary citrate excretion in calcium stone formers.
Cupisti A; Meola M; D'Alessandro C; Bernabini G; Pasquali E; Carpi A; Barsotti G
Biomed Pharmacother; 2007 Jan; 61(1):86-90. PubMed ID: 17184967
[TBL] [Abstract][Full Text] [Related]
20. Anatomic and metabolic risk factors for nephrolithiasis in patients with autosomal dominant polycystic kidney disease.
Grampsas SA; Chandhoke PS; Fan J; Glass MA; Townsend R; Johnson AM; Gabow P
Am J Kidney Dis; 2000 Jul; 36(1):53-7. PubMed ID: 10873872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
